Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of (68)Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal (18)F-fluorocholine PET/CT: 1084 examinations

INTRODUCTION: Despite growing evidence of a superior diagnostic performance of (68)Ga-PSMA-11 over (18)F-fluorocholine (FCH) PET/CT, the number of PET/CT centres able to label on site with gallium-68 is still currently limited. Therefore, patients with biochemical recurrence (BCR) of prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevalme, Yanna-Marina, Boudali, Lotfi, Gauthé, Mathieu, Rousseau, Caroline, Skanjeti, Andrea, Merlin, Charles, Robin, Philippe, Giraudet, Anne-Laure, Janier, Marc, Talbot, Jean-Noël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263442/
https://www.ncbi.nlm.nih.gov/pubmed/33416958
http://dx.doi.org/10.1007/s00259-020-05086-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263442/
https://www.ncbi.nlm.nih.gov/pubmed/33416958
http://dx.doi.org/10.1007/s00259-020-05086-1

Ejemplares similares